Dr. Robert Hanson is co-chair of Dentons' US Intellectual Property and Technologypractice. His practice focuses on patent counseling and prosecution in biotechnology and the life sciences.
With experience handling biotechnology patents for leading industry, university and non-profit clients, Robert has prosecuted more than two thousand patents to issue in the US and has managed foreign patent portfolios pending in countries around the world. Patents issued from these portfolios cover technologies making up some of the world's most successful commercial biotechnology products.
His patent experience includes prosecuting patent applications, invalidity/non-infringement opinions, counseling, patent interference proceedings, reissues, European patent oppositions, appeals and all aspects of strategic patent portfolio management and evaluation. Technologies involved in these representations include biofuels, biological assays, food compositions, genetically modified organisms, genetic transformation technology, nucleic acids and DNA vectors, pharmaceuticals, plant breeding and biotechnology, antibodies, microfluidics, cosmetics, business methods and animal sciences.
Robert has successfully argued numerous appeals before the US Patent Office Board of Patent Appeals and Interferences. These appeals have substantially changed examination policy in key areas of technology.